Idiopathic Pulmonary Fibrosis

Healio compiled the most-read news in pulmonology posted in October.

NASHVILLE, Tenn. — Delayed diagnosis of pulmonary fibrosis is an unfortunate reality for many patients, but experts are seeking to address this problem by closing knowledge gaps and increasing awareness of the disease.

NASHVILLE, Tenn. — Idiopathic pulmonary fibrosis appeared associated with increased mortality rates and worse outcomes among in-hospital cardiac arrest survivors, according to study results presented at the CHEST Annual Meeting.

A new screening tool, the zero-burden comorbidity risk score for idiopathic pulmonary fibrosis, led to earlier diagnosis of IPF and improved outcomes of disease-modifying therapies and other interventions, according to published data.

Almost one-third of patients with idiopathic pulmonary fibrosis had an incidental diagnosis, with survival outcomes still comparably poor to those diagnosed non-incidentally, according to a study published in Respiratory Medicine.

Patients with pulmonary hypertension associated with interstitial lung disease had better outcomes with a higher dose of inhaled treprostinil, as compared with a lower dose or placebo, according to a study.

In a large cohort of male Vietnam veterans, presumptive exposure to Agent Orange led to an increased risk for developing idiopathic pulmonary fibrosis, according to a study.

Use of electronic monitoring systems helped identify prevalent medication nonadherence in patients with idiopathic pulmonary fibrosis taking pirfenidone, according to data published in ERJ Open Research.

Concomitant medication burden is associated with antifibrotic medication intolerance among patients with idiopathic pulmonary fibrosis, according to research published in Annals of the American Thoracic Society.

SAN FRANCISCO — A session at the American Thoracic Society International Conference highlighted a new clinical practice guideline addressing idiopathic pulmonary fibrosis and progressive pulmonary fibrosis in adults.